Should the Use of Selective Serotonin Reuptake Inhibitors in Child and Adolescent Depression Be Banned?
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: European and US pharmaceutical agencies have recently warned against the use of selective serotonin reuptake inhibitors (SSRIs) in child and adolescent depression. This came as a surprise to many practitioners, who had made treatment decisions based on data from pharmaceutical trials using adult samples. Method: The author reviews the recent literature relevant to the use of SSRIs in youth depression, including psychiatricclinical trials, pharmacology and drug safety data. Recommendations and rationales for the use of SSRIs in this context are offered. Results: Ten publications, comprising a total of 2,046 patients, evaluated the efficacy of four SSRIs (fluoxetine, paroxetine, sertraline and citalopram) in child and adolescent depression. It is noted that an additional 6 trials (with a total of 1,234 patients) were not reported by the industry because of a lack of efficacy or problematic side effects, including suicidal behaviors. Meta-analyses revealed no data supporting the use of SSRIs, except for fluoxetine. To formulate recommendations for clinical practice, it is necessary to examine specific issues such as (1) the link between SSRIs, depression and suicidal risk; (2) SSRI age-related specific effects, and (3) the high placebo response in child and adolescent depression. Conclusion: An SSRI prescription is still a second-line option in severe and resistant forms of youth depression. However, in children and adolescents only specialists well trained in child and adolescent psychiatry should prescribe SSRIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Childhood and adolescent depression: a review of the past 10 years, Part I
BIRMAHER, B., RYAN, N. D., WILLIAMSON, D. E., BRENT, D. A., KAUFMAN, J., DAHL, R. E., PEREL, J., & NELSON, B. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00011 · Cited by 2,076
Brent, D. A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210125017 · Cited by 753
KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641
Efficacy of interpersonal psychotherapy for depressed adolescents
Mufson, L. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.573 · Cited by 552
A Randomized Effectiveness Trial of Interpersonal Psychotherapy forDepressed Adolescents
Mufson, L., Dorta, K. P., Wickramaratne, P., Nomura, Y., Olfson, M., & Weissman, M. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.577 · Cited by 537 · cited 1×
“When a patient is included in a pharmacological trial, he or she cannot be representative of all depressed youths from a therapeutic alliance care perspective, since we have to obtain written consent from both the child or the adolescents and their parents after careful and complete information has been given. Thus th…”
BackgroundDifferences in Early Childhood Risk Factors for Juvenile-Onset and Adult-Onset Depression
Jaffee, S. R., Moffitt, T. E., Caspi, A., Fombonne, E., Poulton, R., & Martin, J. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.3.215 · Cited by 472 · cited 1×
“]. Here I note only one study with particularly robust methodology. In a prospective birth cohort where risk factors were gathered until the age of 9, Jaffee et al. [”
BackgroundSuicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424 · cited 1×
“compared four drugs (amitriptyline, fluoxetine, paroxetine and atotiepine) for treatment of adult major depression. The results showed an increase of suicidal risk in each group, albeit limited to the first 10 days of treatment. The authors had in fact shown an old finding, often quoted in pharmacology manuals (e.g. t…”
BackgroundPerlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
The specificity versus nonspecificity dilemma: toward identifying therapeutic change agents
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.687 · Cited by 215
Cited by
Zhou, X., Hetrick, S. E., Cuijpers, P., Qin, B., Barth, J., Whittington, C. J., Cohen, D., Del Giovane, C., Liu, Y., Michael, K. D., et al. (2015) · World Psychiatry · doi:10.1002/wps.20217 · Cited by 322
Self-citationEarly Identification and Intervention in Depressive Disorders: Towards a Clinical Staging Model
Hetrick, S. E., Parker, A. G., Hickie, I. B., Purcell, R., Yung, A. R., & McGorry, P. D. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000140085 · Cited by 186
Offidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345316 · Cited by 94
Dudley, M., Hadzi-Pavlovic, D., Andrews, D., & Perich, T. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802050538 · Cited by 15
Frölich, J., Lehmkuhl, G., & Döpfner, M. (2010) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.a000002 · Cited by 5
Metadata
- Authors
- Cohen, D.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2006-12-08
- Volume
- 76
- Issue
- 1
- Pages
- 5-14
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2153612952
- Cited by
- 62
- References
- 11
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Should the Use of Selective Serotonin Reuptake Inhibitors in Child and Adolescent Depression Be Banned? https://app.cochat.ai/papers/10.1159/000096360
- The paper
- Cohen, D. (2007). Should the Use of Selective Serotonin Reuptake Inhibitors in Child and Adolescent Depression Be Banned? Psychotherapy and Psychosomatics. https://doi.org/10.1159/000096360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.